GPER1 and hemorrhage: Pharmacological modulation further demonstrated that the GPR30 agonist G1 partially ameliorated neurological deficits and reduced cerebral edema/hemorrhage in SAH rats, whereas the antagonist G15 exacerbated brain injury and behavioral impairments.